Resistance to commonly used malaria drugs is spreading and new drugs are re
quired urgently. The recent identification of a relict chloroplast (apicopl
ast) in malaria and related parasites offers numerous new targets for drug
therapy using well-characterized compounds. The apicoplast contains a range
of metabolic pathways and housekeeping processes that differ radically to
those of the host thereby presenting ideal strategies for drug therapy. Ind
eed, many compounds targeting these plastid pathways are antimalarial and h
ave favourable profiles based on extensive knowledge from their use as anti
bacterials. (C) 2001 Harcourt Publishers Ltd.